Smoking behavior characteristics of non-selected smokers with childhood attention-deficit/hyperactivity disorder (AD/HD) history: a systematic review and meta-analysis

  • Guillaume Fond
  • Anderson Loundou
  • Sebastien Guillaume
  • Xavier Quantin
  • Alexandra Macgregor
  • Régis Lopez
  • Philippe Courtet
  • Paquito Bernard
  • Daniel Bailly
  • Mocrane Abbar
  • Marion Leboyer
  • Laurent Boyer
Original Paper

Abstract

It is unclear whether adult smokers with childhood attention-deficit/hyperactivity disorder history (CH) have more severe smoking behavior than non-CH smokers, while it is clearly suggested that CH adolescents have more severe smoking behavior than CH adolescents. The aim of the present comprehensive meta-analysis is to determine whether CH smokers have more severe smoking behavior characteristics than those without and the effect of age on the association between CH and smoking behavior. We included all case–control studies and first round data collection of observational studies addressing the difference in smoking behavior characteristics of CH smokers versus non-CH smokers, with validated scales or structured interviews, without any language or date restriction. Nine studies (including 365 smokers with CH and 1,708 smokers without) were included. Compared to non-CH smokers, CH smokers smoked significantly more cigarettes [standardized mean differences (SMD) = 0.15, 95 % CI 0.01–0.28, p = 0.04] and began to regularly smoke earlier (SMD = −0.28, 95 % CI −0.49; −0.07, p = 0.01) but were not significantly more nicotine dependent (SMD = 0.23, 95 % CI −0.04 to 0.48, p = 0.08). After removing the single adolescent study, the significant association between CH and number of daily smoked cigarettes disappeared, and subgroups analyses confirmed that the significant association between CH and number of daily smoked cigarettes disappeared as age increased. Our meta-analysis illustrates a clinically important link between CH and tobacco smoking in adolescence but not later in life. Further high-quality studies are needed to confirm this finding, as only two studies included participants with a mean age below 20 years.

Keywords

Attention-deficit/hyperactivity disorder (AD/HD) Smoking Nicotine dependence Tobacco 

Notes

Acknowledgments

We express all our thanks to the patients who participated in the studies included in the present meta-analysis, and all the authors that answered us for completing missing data. This work was supported by INSERM, Assistance Publique-Hôpitaux de Paris, RTRS Santé Mentale (Fondation Fondamental) and was supported (in part) by the Investissements d’Avenir program managed by the ANR under reference ANR-11-IDEX-0004-02.

Conflict of interest

None declared.

References

  1. 1.
    APA (2000) American psychiatric association. http://www.psych.org/
  2. 2.
    Bayle FJ, Krebs MO, Martin C, Bouvard MP, Wender P (2003) French version of Wender Utah Rating Scale (WURS). Can J Psychiatry 48:132PubMedGoogle Scholar
  3. 3.
    Berlin I, Hu MC, Covey LS, Winhusen T (2012) Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD. Drug Alcohol Depend 124:268–273PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, Faraone SV (2012) Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 73:941–950PubMedCrossRefGoogle Scholar
  5. 5.
    Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, ChichesterCrossRefGoogle Scholar
  6. 6.
    Bron TI, Bijlenga D, Kasander MV, Spuijbroek AT, Beekman AT, Kooij JJ (2013) Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study. Eur Neuropsychopharmacol 23:542–554PubMedCrossRefGoogle Scholar
  7. 7.
    Caci HM, Bouchez J, Bayle FJ (2010) An aid for diagnosing attention-deficit/hyperactivity disorder at adulthood: psychometric properties of the French versions of two Wender Utah Rating Scales (WURS-25 and WURS-K). Compr Psychiatry 51:325–331PubMedCrossRefGoogle Scholar
  8. 8.
    Covey LS, Manubay J, Jiang H, Nortick M, Palumbo D (2008) Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis. Nicotine Tob Res 10:1717–1725PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Covey LS, Hu MC, Winhusen T, Weissman J, Berlin I, Nunes EV (2010) Oros-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences. Drug Alcohol Depend 110:156–159PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRefGoogle Scholar
  11. 11.
    Fond G, Guillaume S, Jaussent I, Beziat S, Macgregor A, Bernard P, Courtet P, Bailly D, Quantin X (2013) Prevalence and smoking behavior characteristics of nonselected smokers with childhood and/or adult self-reported ADHD symptoms in a smoking-cessation program: a cross-sectional study. J Atten Disord [Epub ahead of print]Google Scholar
  12. 12.
    Gehricke JG, Whalen CK, Jamner LD, Wigal TL, Steinhoff K (2006) The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: a preliminary examination. Nicotine Tob Res 8:37–47PubMedCrossRefGoogle Scholar
  13. 13.
    Gehricke JG, Hong N, Wigal TL, Chan V, Doan A (2011) Adhd medication reduces cotinine levels and withdrawal in smokers with ADHD. Pharmacol Biochem Behav 98:485–491PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Hammerness P, Joshi G, Doyle R, Georgiopoulos A, Geller D, Spencer T, Petty CR, Faraone SV, Biederman J (2013) Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr 162(22–27):e22CrossRefGoogle Scholar
  15. 15.
    Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86:1119–1127PubMedCrossRefGoogle Scholar
  16. 16.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Humfleet GL, Prochaska JJ, Mengis M, Cullen J, Munoz R, Reus V, Hall SM (2005) Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res 7:453–460PubMedCrossRefGoogle Scholar
  18. 18.
    Karp I, O’Loughlin J, Paradis G, Hanley J, Difranza J (2005) Smoking trajectories of adolescent novice smokers in a longitudinal study of tobacco use. Ann Epidemiol 15:445–452PubMedCrossRefGoogle Scholar
  19. 19.
    Kollins SH, McClernon FJ, Van Voorhees EE (2010) Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD). Exp Clin Psychopharmacol 18:221–228PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Laucht M, Hohm E, Esser G, Schmidt MH, Becker K (2007) Association between ADHD and smoking in adolescence: shared genetic, environmental and psychopathological factors. J Neural Transm 114:1097–1104PubMedCrossRefGoogle Scholar
  21. 21.
    Lee W, Bindman J, Ford T, Glozier N, Moran P, Stewart R, Hotopf M (2007) Bias in psychiatric case–control studies: literature survey. Br J Psychiatry 190:204–209PubMedCrossRefGoogle Scholar
  22. 22.
    Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH (2001) Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob Res 3:353–359PubMedCrossRefGoogle Scholar
  23. 23.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMedGoogle Scholar
  24. 24.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMedGoogle Scholar
  25. 25.
    Matthies S, Holzner S, Feige B, Scheel C, Perlov E, Ebert D, Tebartz van Elst L, Philipsen A (2013) ADHD as a serious risk factor for early smoking and nicotine dependence in adulthood. J Atten Disord 17(3):176–186. doi: 10.1177/1087054711428739 Google Scholar
  26. 26.
    McCann BS, Scheele L, Ward N, Roy-Byrne P (2000) Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 12:240–245PubMedCrossRefGoogle Scholar
  27. 27.
    McClernon FJ, Kollins SH, Lutz AM, Fitzgerald DP, Murray DW, Redman C, Rose JE (2008) Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology 197:95–105PubMedCrossRefGoogle Scholar
  28. 28.
    McClernon FJ, Van Voorhees EE, English J, Hallyburton M, Holdaway A, Kollins SH (2011) Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial. Nicotine Tob Res 13:784–792PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Modesto-Lowe V, Danforth JS, Neering C, Easton C (2010) Can we prevent smoking in children with ADHD: a review of the literature. Conn Med 74:229–236PubMedGoogle Scholar
  30. 30.
    Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(6):e1000097. doi: 10.1371/journal.pmed1000097 PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Monuteaux MC, Spencer TJ, Faraone SV, Wilson AM, Biederman J (2007) A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. J Clin Psychiatry 68:1094–1101PubMedCrossRefGoogle Scholar
  32. 32.
    Palmer RH, Knopik VS, Rhee SH, Hopfer CJ, Corley RC, Young SE, Stallings MC, Hewitt JK (2013) Prospective effects of adolescent indicators of behavioral disinhibition on DSM-IV alcohol, tobacco, and illicit drug dependence in young adulthood. Addict Behav 38:2415–2421PubMedCrossRefGoogle Scholar
  33. 33.
    Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF (2003) Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addict Behav 28:1149–1157PubMedCrossRefGoogle Scholar
  34. 34.
    Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rossler M (2002) Wender Utah Rating Scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults. Nervenarzt 73:830–838PubMedCrossRefGoogle Scholar
  35. 35.
    Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Georg T, Supprian T, Wender PH, Rosler M (2003) Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder. Nervenarzt 74:987–993PubMedCrossRefGoogle Scholar
  36. 36.
    Romo L, Legauffre C, Mille S, Cheze N, Fougeres AL, Marquez S, Excoffier A, Dubertret C, Ades J (2010) Psychometric properties of the French version of the Wender Utah Rating Scale and brown’s attention deficit disorders scale for adults. Encephale 36:380–389PubMedCrossRefGoogle Scholar
  37. 37.
    Rossini ED, O’Connor MA (1995) Retrospective self-reported symptoms of attention-deficit hyperactivity disorder: reliability of the Wender Utah Rating Scale. Psychol Rep 77:751–754PubMedCrossRefGoogle Scholar
  38. 38.
    Rush CR, Higgins ST, Vansickel AR, Stoops WW, Lile JA, Glaser PE (2005) Methylphenidate increases cigarette smoking. Psychopharmacology 181:781–789PubMedCrossRefGoogle Scholar
  39. 39.
    Stein MA, Sandoval R, Szumowski E, Roizen N, Reinecke MA, Blondis TA, Klein Z (1995) Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women. Psychopharmacol Bull 31:425–433PubMedGoogle Scholar
  40. 40.
    Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002PubMedCrossRefGoogle Scholar
  41. 41.
    Stoops WW, Poole MM, Vansickel AR, Hays KA, Glaser PE, Rush CR (2011) Methylphenidate increases choice of cigarettes over money. Nicotine Tob Res 13:29–33PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Tercyak KP, Audrain-McGovern J (2003) Personality differences associated with smoking experimentation among adolescents with and without comorbid symptoms of ADHD. Subst Use Misuse 38:1953–1970PubMedCrossRefGoogle Scholar
  43. 43.
    Vansickel AR, Stoops WW, Glaser PE, Poole MM, Rush CR (2011) Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology (Berl) 218(2):381–390. doi: 10.1007/s00213-011-2328-y CrossRefGoogle Scholar
  44. 44.
    Vassos E, Collier DA, Fazel S (2013) Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression. Mol Psychiatry. doi: 10.1038/mp.2013.31
  45. 45.
    Ward MF, Wender PH, Reimherr FW (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885–890PubMedGoogle Scholar
  46. 46.
    Wheeler TL, Smith LN, Bachus SE, McDonald CG, Fryxell KJ, Smith RF (2013) Low-dose adolescent nicotine and methylphenidate have additive effects on adult behavior and neurochemistry. Pharmacol Biochem Behav 103:723–734PubMedCrossRefGoogle Scholar
  47. 47.
    Wilens TE, Vitulano M, Upadhyaya H, Adamson J, Sawtelle R, Utzinger L, Biederman J (2008) Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr 153(3):414–419. doi: 10.1016/j.jpeds.2008.04.030 Google Scholar
  48. 48.
    Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM (2010) Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 71:1680–1688PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC (2011) Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 21:455–463PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Guillaume Fond
    • 1
  • Anderson Loundou
    • 4
  • Sebastien Guillaume
    • 2
  • Xavier Quantin
    • 3
  • Alexandra Macgregor
    • 2
  • Régis Lopez
    • 5
  • Philippe Courtet
    • 2
  • Paquito Bernard
    • 3
  • Daniel Bailly
    • 5
    • 7
  • Mocrane Abbar
    • 6
  • Marion Leboyer
    • 1
  • Laurent Boyer
    • 4
  1. 1.Pôle de Psychiatrie des Hôpitaux Universitaires H Mondor, INSERM U955, Eq 15, Fondation FondaMental, Fondation de Coopération Scientifique en Santé MentaleUniversité Paris EstCréteilFrance
  2. 2.Inserm U1061, Montpellier, Services Universitaires de Psychiatrie, CHU MontpellierUniversité Montpellier 1MontpellierFrance
  3. 3.Département Universitaire de Pneumologie et d’addictologie, Epsylon EA 4556, Institut Régional du Cancer de Montpellier, CHU MontpellierUniversité Montpellier 1MontpellierFrance
  4. 4.EA 3279 – Public Health, Chronic Diseases and Quality of Life - Research UnitAix-Marseille UnitMarseilleFrance
  5. 5.INSERM 1061, Centre de Reference National Narcolepsie Hypersomnie Idiopathique, Unité des Troubles du Sommeil, CHU MontpellierUniversité Montpellier 1MontpellierFrance
  6. 6.CHU Carémeau, service de psychiatrie adulteUniversité de NîmesNîmesFrance
  7. 7.Service hospitalo-universitaire de psychiatrie, Hôpital Sainte-MargueriteMarseilleFrance

Personalised recommendations